Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire

Validation and Reliability of the Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q)

This study aims to evaluate the psychometric properties of the Turkish version of the Parent-reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q), a disease-specific instrument assessing the health-related quality of life (HRQoL) in caregivers of children with suspected or confirmed drug hypersensitivity reactions. The P-DrHy-Q is designed to capture the psychosocial burden experienced by caregivers and includes two main domains: Mental Health and Social Activity. This study involves a forward-backward translation process, cultural adaptation, internal consistency analysis, and test-retest reliability assessment in a Turkish caregiver population.

Inclusion Criteria:

• Age ≥ 18 years
• Primary caregiver of a child under the age of 18
• Child must have a documented history of drug hypersensitivity
• Fluent in written and spoken Turkish
• Willingness to participate and provide written informed consent
• Availability to complete both baseline and follow-up questionnaire within the designated time frame

Exclusion Criteria:

• Caregivers with diagnosed psychiatric or cognitive disorders
• Inability to read or write in Turkish
• Child currently experiencing an acute drug hypersensitivity reaction
• Previous participation in the pilot testing phase of this validation study